ARTA
IPCI

A.R.T. Advisors’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

A.R.T. Advisors’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5,282
Closed -$52K – 1836
2017
Q3 		$52K Buy
+5,282
New +$75.4K ﹤0.01% 1256
2014
Q4 		– Sell
-1,791
Closed -$53K – 1785
2014
Q3 		$53K Buy
+1,791
New +$51.6K ﹤0.01% 1241

Other funds holding IPCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $2.95B AUM 22.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return
VAM
Verity Asset Management Durham, North Carolina $238M AUM 24.8% 1-Year Est. Return

A.R.T. Advisors's IPCI Position: Q4 2017 in Review

A.R.T. Advisors sold out of Intellipharmaceuticals International Inc. (IPCI) in Q4 2017, closing a stake of 5,282 shares — an estimated $52K sold.

A.R.T. Advisors first reported a position in IPCI in Q3 2014 and held it in 2 quarters. The position peaked at $53K in Q3 2014. 28 funds tracked by Wall St. Rank hold IPCI as of Q4 2017.

  • A.R.T. Advisors reported no remaining Intellipharmaceuticals International Inc. position as of Q4 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 5,282 Intellipharmaceuticals International Inc. shares in Q4 2017, an estimated $52K.
  • A.R.T. Advisors first reported a position in Intellipharmaceuticals International Inc. in Q3 2014 and held it in 2 quarters.
  • A.R.T. Advisors's Intellipharmaceuticals International Inc. position peaked at $53K in Q3 2014.
  • 28 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q4 2017.

Based on A.R.T. Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.